comparemela.com

Latest Breaking News On - Claus lindbjerg andersen - Page 1 : comparemela.com

Risk for CRC Recurrence After Surgery Is Falling

Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposium

Natera to Present New Colorectal Cancer Data at the 2021 ASCO GI Symposium Oral presentation showcases the largest early-stage CRC cohort to date, further validating the serial use of Signatera™ for early recurrence detection and MRD assessment News provided by Share this article SAN CARLOS, Calif., Jan. 12, 2021 /PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and tumor-informed molecular residual disease (MRD) test, Signatera, at the American Society of Clinical Oncology s 2021 Gastrointestinal Cancers Symposium (ASCO GI), taking place January 15-17, 2021. Natera will have one oral and one poster presentation, each describing the clinical performance of Signatera in patients with colorectal cancer (CRC).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.